1,5-Dimethoxy-3-methyl-pentan | 4457-73-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,5-Dimethoxy-3-methyl-pentan
• 英文别名: 1,5-dimethoxy-3-methyl-pentane；1,5-Dimethoxy-3-methylpentane
• CAS: 4457-73-2
• 化学式: C₈H₁₈O₂
• 分子量: 146.23
• InChiKey: QZXWSCAEICODIW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1,5-二溴-3-甲基戊烷 、 sodium methylate 生成 1,5-Dimethoxy-3-methyl-pentan
  参考文献：
  名称：

  Wartski,L., Bulletin de la Societe Chimique de France, 1965, p. 3066 - 3076

  摘要：

  DOI：

文献信息

• SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES
  申请人：Lindsey Jonathan S.

  公开号：US20090227553A1

  公开（公告）日：2009-09-10

  The present invention provides compounds of the general Formula DI: along with methods of making such compounds, formulations containing the same, and methods of using the same (e.g., in photodynamic therapy, for the production of solar cells, etc.)

  本发明提供了一般公式DI的化合物，以及制备此类化合物的方法，包含此类化合物的配方，以及使用此类化合物的方法（例如，用于光动力疗法，用于太阳能电池的生产等）。
• N-Terminal Pegylated Prolactin Receptor Molecules
  申请人：Peschke Bernd

  公开号：US20100035814A1

  公开（公告）日：2010-02-11

  The invention is concerned with N-terminally pegylated polypeptides capable of binding to the prolactin receptor. Such polypeptides may for instance be N-terminally pegylated antagonists of the prolactin receptor, such as for instance prolactin variants.

  本发明涉及能够结合催乳素受体的N-末端聚乙二醇化多肽。这样的多肽可以是催乳素受体的N-末端聚乙二醇化拮抗剂，例如催乳素变异体。
• ESTERS AND ETHERS OF 3-METHYL-PENTAN-DIOL AND UNSATURATED DERIVATES THEREOF AND THEIR USE AS AROMA CHEMICAL
  申请人：BASF SE

  公开号：EP3561029A1

  公开（公告）日：2019-10-30

  The present invention relates to the use of esters of 3-methyl-pentan-diol and unsaturated derivates thereof and ethers of 3-methyl-pentan-diol and unsaturated derivates thereof as aroma chemicals, to aroma chemical compositions comprising at least one ester of 3-methyl-pentan-diol and unsaturated derivates thereof and/or at least one ether of 3-methyl-pentan-diol and unsaturated derivates thereof and to a method for preparing a fragranced composition in particular a fragranced ready-to-use composition, which comprises incorporating at least one ester of 3-methyl-pentan-diol and unsaturated derivates thereof and/or at least one ether 3-methyl-pentan-diol and unsaturated derivates thereof into a composition, in particular into a ready-to-use composition. The present invention further relates to specific ethers 3-methyl-pentan-diol and unsaturated derivates thereof and specific esters 3-methyl-pentan-diol and unsaturated derivates thereof and a method for their preparation.

  本发明涉及 3-甲基-戊二醇及其不饱和衍生物的酯类和 3-甲基-戊二醇及其不饱和衍生物的醚类作为芳香化学品的用途，涉及包含至少一种 3-甲基-戊二醇及其不饱和衍生物的酯类和/或至少一种 3-甲基-戊二醇及其不饱和衍生物的醚类的芳香化学品组合物，还涉及一种制备芳香组合物，特别是芳香即用组合物的方法、该方法包括将至少一种 3-甲基-戊二醇酯及其不饱和衍生物和/或至少一种 3-甲基-戊二醇醚及其不饱和衍生物加入组合物中，特别是加入即用型组合物中。本发明还涉及特定的 3-甲基-戊二醇醚及其不饱和衍生物和特定的 3-甲基-戊二醇酯及其不饱和衍生物，以及它们的制备方法。
• ESTERS AND ETHERS OF 3-METHYL-PENTANE-DIOL AND UNSATURATED DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICAL
  申请人：BASF SE

  公开号：EP3784762A1

  公开（公告）日：2021-03-03
• SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS
  申请人：Kandimalla Ekambar R.

  公开号：US20080206265A1

  公开（公告）日：2008-08-28

  The invention relates to the therapeutic use of immunostimulatory oligonucleotides and/or immunomers in combination with chemotherapeutic agents to provide a synergistic therapeutic effect.